iThera Medical GmbH develops and markets biomedical imaging systems based on optoacoustics. iThera Medical was founded in 2010 and has commercialized MSOT and RSOM with system placements across Europe, North America and Asia. It has established its own distribution and sales network, including international service capacity and has recently been awarded CE mark for its first clinical device. iThera Medical will serve a dual role in the INNODERM project. First, they will drive the development of fast RSOM, and second, being committed to establishing optoacoustic imaging as an important imaging modality for the research of biomedical processes, clinical diagnosis and treatment follow up, they will lead the exploitation activities of the project.